LuciBelzu 40 mg Tablet

Molecule: Belzutifan

Strength: 40 mg

Quantity: 90 Tablets

Form: Tablet

Packaging Type: Bottle

Manufacturer/Marketed By: Lucius Pharma

Country of Origin: Laos

No similar products found.

Overview

- Introduction

Description

Active Ingredient: Each tablet contains Belzutifan 40 mg.

Indications: LuciBelzu is a hypoxia-inducible factor (HIF) inhibitor indicated for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated:

Renal cell carcinoma (RCC)
Central nervous system (CNS) hemangioblastomas
Pancreatic neuroendocrine tumors (pNET)

Note: Not intended for patients requiring immediate surgery.

Dosage & Administration:

Recommended dose: 120 mg (three 40 mg tablets) taken orally once daily, with or without food.
Swallow tablets whole; do not crush or split.

Reviews

Clear filters

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Call : +63 952 488 3302

LuciBelzu 40 mg Tablet

Please fill in the details below, and we’ll get back to you as soon as possible

Description

Related Posts:

Reviews

Please fill in the details below, and we’ll get back to you as soon as possible